Cargando…

Quantifying early COVID-19 outbreak transmission in South Africa and exploring vaccine efficacy scenarios

The emergence and fast global spread of COVID-19 has presented one of the greatest public health challenges in modern times with no proven cure or vaccine. Africa is still early in this epidemic, therefore the extent of disease severity is not yet clear. We used a mathematical model to fit to the ob...

Descripción completa

Detalles Bibliográficos
Autores principales: Mukandavire, Zindoga, Nyabadza, Farai, Malunguza, Noble J., Cuadros, Diego F., Shiri, Tinevimbo, Musuka, Godfrey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7380646/
https://www.ncbi.nlm.nih.gov/pubmed/32706790
http://dx.doi.org/10.1371/journal.pone.0236003
_version_ 1783562891072372736
author Mukandavire, Zindoga
Nyabadza, Farai
Malunguza, Noble J.
Cuadros, Diego F.
Shiri, Tinevimbo
Musuka, Godfrey
author_facet Mukandavire, Zindoga
Nyabadza, Farai
Malunguza, Noble J.
Cuadros, Diego F.
Shiri, Tinevimbo
Musuka, Godfrey
author_sort Mukandavire, Zindoga
collection PubMed
description The emergence and fast global spread of COVID-19 has presented one of the greatest public health challenges in modern times with no proven cure or vaccine. Africa is still early in this epidemic, therefore the extent of disease severity is not yet clear. We used a mathematical model to fit to the observed cases of COVID-19 in South Africa to estimate the basic reproductive number and critical vaccination coverage to control the disease for different hypothetical vaccine efficacy scenarios. We also estimated the percentage reduction in effective contacts due to the social distancing measures implemented. Early model estimates show that COVID-19 outbreak in South Africa had a basic reproductive number of 2.95 (95% credible interval [CrI] 2.83–3.33). A vaccine with 70% efficacy had the capacity to contain COVID-19 outbreak but at very higher vaccination coverage 94.44% (95% Crl 92.44–99.92%) with a vaccine of 100% efficacy requiring 66.10% (95% Crl 64.72–69.95%) coverage. Social distancing measures put in place have so far reduced the number of social contacts by 80.31% (95% Crl 79.76–80.85%). These findings suggest that a highly efficacious vaccine would have been required to contain COVID-19 in South Africa. Therefore, the current social distancing measures to reduce contacts will remain key in controlling the infection in the absence of vaccines and other therapeutics.
format Online
Article
Text
id pubmed-7380646
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-73806462020-07-27 Quantifying early COVID-19 outbreak transmission in South Africa and exploring vaccine efficacy scenarios Mukandavire, Zindoga Nyabadza, Farai Malunguza, Noble J. Cuadros, Diego F. Shiri, Tinevimbo Musuka, Godfrey PLoS One Research Article The emergence and fast global spread of COVID-19 has presented one of the greatest public health challenges in modern times with no proven cure or vaccine. Africa is still early in this epidemic, therefore the extent of disease severity is not yet clear. We used a mathematical model to fit to the observed cases of COVID-19 in South Africa to estimate the basic reproductive number and critical vaccination coverage to control the disease for different hypothetical vaccine efficacy scenarios. We also estimated the percentage reduction in effective contacts due to the social distancing measures implemented. Early model estimates show that COVID-19 outbreak in South Africa had a basic reproductive number of 2.95 (95% credible interval [CrI] 2.83–3.33). A vaccine with 70% efficacy had the capacity to contain COVID-19 outbreak but at very higher vaccination coverage 94.44% (95% Crl 92.44–99.92%) with a vaccine of 100% efficacy requiring 66.10% (95% Crl 64.72–69.95%) coverage. Social distancing measures put in place have so far reduced the number of social contacts by 80.31% (95% Crl 79.76–80.85%). These findings suggest that a highly efficacious vaccine would have been required to contain COVID-19 in South Africa. Therefore, the current social distancing measures to reduce contacts will remain key in controlling the infection in the absence of vaccines and other therapeutics. Public Library of Science 2020-07-24 /pmc/articles/PMC7380646/ /pubmed/32706790 http://dx.doi.org/10.1371/journal.pone.0236003 Text en © 2020 Mukandavire et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Mukandavire, Zindoga
Nyabadza, Farai
Malunguza, Noble J.
Cuadros, Diego F.
Shiri, Tinevimbo
Musuka, Godfrey
Quantifying early COVID-19 outbreak transmission in South Africa and exploring vaccine efficacy scenarios
title Quantifying early COVID-19 outbreak transmission in South Africa and exploring vaccine efficacy scenarios
title_full Quantifying early COVID-19 outbreak transmission in South Africa and exploring vaccine efficacy scenarios
title_fullStr Quantifying early COVID-19 outbreak transmission in South Africa and exploring vaccine efficacy scenarios
title_full_unstemmed Quantifying early COVID-19 outbreak transmission in South Africa and exploring vaccine efficacy scenarios
title_short Quantifying early COVID-19 outbreak transmission in South Africa and exploring vaccine efficacy scenarios
title_sort quantifying early covid-19 outbreak transmission in south africa and exploring vaccine efficacy scenarios
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7380646/
https://www.ncbi.nlm.nih.gov/pubmed/32706790
http://dx.doi.org/10.1371/journal.pone.0236003
work_keys_str_mv AT mukandavirezindoga quantifyingearlycovid19outbreaktransmissioninsouthafricaandexploringvaccineefficacyscenarios
AT nyabadzafarai quantifyingearlycovid19outbreaktransmissioninsouthafricaandexploringvaccineefficacyscenarios
AT malunguzanoblej quantifyingearlycovid19outbreaktransmissioninsouthafricaandexploringvaccineefficacyscenarios
AT cuadrosdiegof quantifyingearlycovid19outbreaktransmissioninsouthafricaandexploringvaccineefficacyscenarios
AT shiritinevimbo quantifyingearlycovid19outbreaktransmissioninsouthafricaandexploringvaccineefficacyscenarios
AT musukagodfrey quantifyingearlycovid19outbreaktransmissioninsouthafricaandexploringvaccineefficacyscenarios